Investigator's Initiated Phase II Study for Pancreatic Cancer Patients

Summary

The purpose of this study is to evaluate the efficacy, safety and tolerability of TL-118 alone or in combination with pancreatic cancer chemotherapy.

Timeline

Start

2013-12

Primary completion

2014-10

Completion

—

Drugs

Indications